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Abstract
Aims/hypothesis Moderate alcohol consumption is associated
with a reduced risk of type 2 diabetes with a stronger effect
in women. As the underlying mechanisms remain poorly
characterised, we investigated its relationship with insulin
resistance, insulin secretion, clearance of insulin and
glucagon concentration.
Methods One-thousand two-hundred and seventy-six
non-diabetic individuals from the RISC (relationship
between insulin sensitivity and cardiovascular disease)
study without high alcohol consumption were studied;
all had a euglycaemic–hyperinsulinaemic clamp and an
OGTT with assessment of insulin sensitivity, secretion
and clearance.
The list of RISC investigators is presented in the electronic
supplementary material (ESM).
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Results Alcohol consumption was positively associated
with insulin sensitivity in women (β00.15, ptrend00.005)
and in men (β00.07, ptrend00.07) after controlling for age,
centre, waist, smoking and physical activity. In women, this
association persisted after adjustment for adiponectin but
was attenuated after controlling for HDL-cholesterol,
suggesting that part of the protection is related to a higher
HDL-cholesterol concentration. Higher alcohol consump-
tion was associated with lower basal insulin secretion in
women only (β0−0.10, ptrend00.004) and this association
persisted after adjustment for insulin sensitivity. In men,
increasing alcohol consumption was associated with en-
hanced insulin clearance and increased fasting NEFA con-
centrations, independently of insulin sensitivity. Fasting
glucagon decreased with increasing alcohol in women only
(abstainers 9.2±4.4; <28 g/week 8.6±4.0; 28–64 g/week
8.1±3.7; >64 g/week 7.5±3.1 pmol/l; ptrend00.01).
Conclusions/interpretation Light-to-moderate alcohol con-
sumption was associated in healthy women with enhanced
insulin sensitivity, reduced basal insulin secretion rate and
lower fasting plasma glucagon concentration, providing
consistent mechanisms for the reduced risk of diabetes.
Keywords Alcohol . Glucagon . Insulin clearance .
Insulin resistance . Insulin secretion
Abbreviations
GGT Gamma glutamyl transferase
IGT Impaired glucose tolerance
RISC Relationship between insulin sensitivity
and cardiovascular disease
Introduction
Epidemiological studies have shown that moderate alcohol
consumption is associated with a reduced risk of type 2
diabetes [1–6]. This has been confirmed by a recent meta-
analysis of observational studies that reported a U-shaped
relationship for both sexes with a risk reduction for a mod-
erate alcohol intake and an increased risk for an intake of
over 50–60 g/day [7]. The relationship differed between
men and women, with a lower RR in women than men for
moderate alcohol intake, compared with alcohol abstainers.
The underlying mechanisms behind this reduction in risk
with moderate alcohol intake remain poorly understood. It
has been proposed that this risk reduction might be
explained by improved insulin sensitivity but this has not
been assessed by the method of reference, the hyperinsuli-
naemic–euglycaemic clamp. Furthermore, the relationship
between alcohol consumption and both glucagon concentra-
tion and insulin secretion has not been previously addressed.
The aim of the present study is to determine the relation-
ship between moderate alcohol intake and both insulin sen-
sitivity (assessed by the hyperinsulinaemic–euglycaemic
clamp) and insulin secretion in a large cohort of healthy men
and women participating in the RISC study (Relationship
between Insulin Sensitivity and Cardiovascular disease
study) [8, 9]. We performed a sex-specific analysis, as mean
alcohol intake was significantly lower in women and
also to determine possible sex differences in the association
between alcohol consumption and glucose metabolism, as
seen in the meta-analysis [7]. Furthermore, we aimed to
explore the potential confounding role of adiponectin and
HDL-cholesterol in mediating the relationship between
alcohol intake and glucose metabolism.
Methods
Study population RISC is a prospective observational co-
hort study whose rationale and methodology have been
published, as well as the characteristics of the individuals
recruited [8, 9]. Clinically healthy men and women, aged
30–60 years, were recruited by advertisement, from the local
populations of 19 centres in 14 European countries. Initial
exclusion criteria were: treatment for obesity, hypertension,
lipid disorders or diabetes, pregnancy, cardiovascular or
chronic lung disease, weight change ≥5 kg in the last
6 months, cancer (in the last 5 years) and renal failure.
Exclusion criteria after screening were: arterial BP ≥140/
90 mmHg, fasting plasma glucose ≥7.0 mmol/l, 2 h plasma
glucose (following a 75 g OGTT) ≥11.0 mmol/l, total serum
cholesterol ≥7.8 mmol/l, serum triacylglycerol ≥4.6
mmol/l and ECG abnormalities. In the present analysis,
we included all the participants who were not ruled out
by these criteria, whose clamp study passed the quality
control check and for whom data on HDL-cholesterol
and alcohol intake were available (n01,289). We also
excluded those (nine men and four women) with a high
alcohol consumption (defined as >350 g/week for men
and >280 g/week for women), as the purpose of the
study was to investigate the metabolic effects of light-
to-moderate alcohol consumption. Therefore, we studied
a total of 1,276 individuals.
At 3 years 563 women and 461 men attended a second
OGTT. Impaired glucose tolerance (IGT), defined as fasting
glucose <7.0 mmol/l and 2 h glucose ≥7.8 mmol/l but
<11 mmol/l or type 2 diabetes, was present in 58 men and
78 women.
Height was measured, and body weight and per cent
body fat were evaluated by the TANITA bioimpedance
balance (Tanita International Division, Arlington Heights,
IL, USA). BMI was calculated and obesity was defined as
BMI ≥30 kg/m2.
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Ethics Committee approval was obtained by each
recruiting centre. Participants were given detailed written
information on the study as well as an oral explanation, and
they all signed a consent form.
Lifestyle and alcohol consumption Alcohol consumption was
assessed using a standardised semiquantitative food-frequency
questionnaire. For each beverage type (beer, red and white
wine, port, vermouth, hard liquor), participants reported
their usual number of glasses and the glass size (small,
medium or large, according to photographs on the question-
naire). The ten frequency response categories ranged from
‘never’ to ‘40 or more times per week’. The consumption
was quantified in grams of pure alcohol per week and then
stratified into four categories: abstainers; by tertiles of alco-
hol intake, for men, <57, 57–130, >130 g/week and for
women, <28, 28–64, >64 g/week.
Information on physical activity was collected with the 7-
day International Physical Activity Questionnaire (IPAQ), a
previously validated assessment tool for international
studies, that provides a comprehensive evaluation of daily
physical-activity habits [10].
OGTT OGTT was performed after a fasting period of at
least 10 h. Blood samples were taken at fasting and 30,
60, 90 and 120 min into the OGTT, together with samples
for central analysis of routine blood chemistry. Blood col-
lected during the studies was separated into plasma and
serum, portioned and stored at −20°C for glucose and insu-
lin and −80°C for lipid analysis.
Glucose concentrations were measured by the glucose
oxidase technique. Plasma insulin and C-peptide were mea-
sured by a two-site time-resolved fluoroimmunoassay
(AutoDELFIA Insulin kit; Wallac, Turku, Finland) using
monoclonal antibodies, with the following assay character-
istics (for insulin and C-peptide, respectively): sensitivity 1–
2 and 5 pmol/l, within-assay variation 5 and 5% and
between-assay variation 5 and 3.5%. Liver enzymes were
centrally assayed on a Dade-Behring Dimension RXL Auto-
analyser (Cambridge, UK). Measurement of plasma NEFA
concentration was carried out using a Randox enzymatic kit
(Randox Laboratories Limited, Crumlin, UK). The CV was
less than 5%. Serum adiponectin was determined by an
in-house time-resolved immunofluorometric assay (TR-
IFMA), based on two antibodies and recombinant human
adiponectin, that measures total circulating adiponectin (in-
cluding high- and low-molecular-mass isoforms) (R & D
Systems, Abingdon, UK) [11]. All standards and unknown
samples were analysed in duplicate, with the exception of
non-specific binding, which was analysed in quadruplicate.
The intra-assay CV was <5% and the inter-assay CV was
<10%. The samples for glucagon assessment were collected
in a tube containing EDTA plus a protease inhibitor
(aprotinin) and repeated freeze–thaw of these samples was
avoided. Glucagon concentration was measured in a central-
ised laboratory in Odense, Denmark by an immunoassay
method that is highly specific for the free C-terminus of the
molecule, and therefore specific for pancreatic glucagon,
with the following assay characteristics: normal range (5–
20 pmol/l) sensitivity <1 pmol/l, within-assay CV <5% at
20 pmol/l, between-assay CV <12% [11].
Insulin sensitivity On a separate day within 1 month of the
OGTT, a hyperinsulinaemic–euglycaemic clamp was per-
formed. Exogenous insulin was administered as a primed
continuous infusion at a rate of 240 pmol min−1m−2 simul-
taneously with a variable 20% dextrose infusion adjusted
every 5–10 min to maintain the plasma glucose concentra-
tion within 0.8 mmol/l (±15%) of the target glucose level
(4.5–5.5 mmol/l). The clamp procedure was standardised
across centres; the data from each clamp study were trans-
ferred to the coordinating centre where they underwent
quality-control scrutiny according to pre-set criteria.
Insulin sensitivity was expressed as the ratio of the M
value during the final 40 min of the 2 h clamp, to the mean
plasma insulin concentration measured during the same
interval (M/I), normalised to fat-free mass and expressed in
units of μmolmin−1 (kg fat free mass)–1 (nmol/l)–1
Insulin secretion Beta cell function was assessed from the
OGTT using a model describing the relationship between
insulin secretion (calculated from C-peptide using the
method of van Cauter et al [12]) and glucose concentra-
tion, previously described in detail [13–15]. From the
model-estimated beta cell dose–response, relating insulin
secretion (in pmol min−1m−2) to glucose concentration,
insulin secretion at 5 mmol/l glucose (the average basal
glucose in the participants with normal glucose tolerance)
was determined. This variable represents insulin secretion
in basal conditions if basal glucose was 5 mmol/l in each
individual. Basal and total (integral during the OGTT, in
nmol/m2) insulin secretion was also determined using the
model.
Insulin clearance Peripheral insulin clearance during the
clamp (in l min−1m−2) was calculated as the ratio between
insulin infusion rate and steady-state insulin concentration
in the last 40 min of the clamp.
The endogenous ‘pre-hepatic’ clearance in basal condi-
tions was defined as: (basal insulin secretion)/(basal insulin
concentration) where basal insulin secretion is calculated
from the beta cell modelling analysis. This clearance value
is directly dependent on hepatic insulin extraction. The
endogeneous ‘pre-hepatic’ insulin clearance during the
OGTT (in l min−1m−2) was defined as the ratio of mean
insulin secretion and mean insulin concentration.
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Statistical analysis The data are expressed as mean±SD or
as median (interquartile range) for variables with a skewed
distribution, and categorical data as percentages. Variables
that were not symmetrically distributed were log trans-
formed before analyses. Data were analysed for men and
women separately.
The mean values of the participant characteristics were
compared across categories of alcohol intake by ANOVA.
Spearman correlation coefficients were first assessed
between alcohol consumption, as expressed in g/week as a
continuous variable, and insulin sensitivity.
The relationships between alcohol intake categories, and
insulin sensitivity, insulin secretion, insulin clearance and
glucagon were assessed by linear regression analysis with
adjustment for age, recruitment centre, physical activity,
current smoking and waist circumference. Trend tests were
determined across the categories of alcohol intake. Next,
HDL-cholesterol, triacylglycerol and adiponectin levels
were added into the regression model. We also tested for
an interaction between BMI ≤25 and >25 kg/m2 with alco-
hol consumption categories on insulin sensitivity. Logistic
regression analysis was used to assess the relationship be-
tween alcohol consumption and the risk of impaired glucose
tolerance or type 2 diabetes at year3, after adjustment for
age and waist circumference. Statistical analyses used
StatView for Windows (version 5.0; SAS Institute, Cary,
NC, USA) and SAS version 9.2.
Results
The percentage of abstainers was higher in women (n0172,
24.4%) than in men (n072, 12.6%). When excluding the
abstainers, the median alcohol intake was 84 g/week (range
7.5–350 g/week) in men and 42 g/week in women (range
7.5–270 g/week).
In women only, moderate alcohol consumption was
associated with a lower BMI and waist circumference and
with a higher prevalence of current smoking (Tables 1, 2).
Fasting and 2 h glycaemia did not differ according to
alcohol consumption categories in either men or women.
In both men and women, there was a graded increase in
plasma HDL-cholesterol and gamma glutamyl transferase
(GGT) across categories of alcohol intake (Tables 1, 2).
Adiponectin concentrations did not significantly differ
according to alcohol consumption categories in either men
or women, but there was a trend for a positive relation in
women (p00.08).
Insulin sensitivity In univariate analysis, alcohol consump-
tion, expressed as a continuous variable, was positively
correlated with insulin sensitivity in women (rSpearman0
0.16, p00.0001) but not in men (rSpearman00.05, p00.20).
When alcohol was used as a categorical variable the results
were very similar, with a significant association in women
(p00.005) but not in men (p00.07), after controlling for
age, recruitment centre, waist, current smoking and physical
activity (Fig. 1). This association persisted after excluding
women who were alcohol abstainers from the analysis. The
significance of the relation between alcohol consumption
categories and insulin sensitivity was only borderline after
controlling for HDL-cholesterol concentration in women
(p00.06), and there was no relation in men (p00.24).
Further adjustment for adiponectin, triacylglycerol or GGT
levels did not alter the significant association between alco-
hol consumption and the M/I value in women. In men, the
relationship between alcohol intake and insulin sensitivity
was stronger after controlling for GGT levels (p00.02).
There was no significant interaction between BMI ≤/
>25 kg/m2 and alcohol consumption on insulin sensitivity
in either sex.
Insulin secretion Basal insulin secretion decreased across
alcohol consumption categories in women but not in
men, after adjusting for age, recruitment centre, smok-
ing, physical activity and waist circumference (Fig. 2).
The significant inverse association between increased
alcohol consumption and basal insulin secretion in
women persisted after controlling for insulin sensitivity
(log M/I) (ptrend00.017) or for HDL-cholesterol, albeit
being attenuated after taking this variable into account
(ptrend00.03).
We also quantified basal insulin secretion, at a fixed
normal glucose level of 5 mmol/l glucose, from the beta
cell dose–response. There was an inverse association be-
tween alcohol intake and insulin secretion at 5 mmol/l glu-
cose in women only, with a progressive decrease in insulin
secretion rate across alcohol consumption categories (see
electronic supplementary material [ESM] Fig. 1). This as-
sociation persisted after controlling for the M/I value, sug-
gesting an effect independent of changes in insulin
sensitivity. Total insulin secretion during the OGTT did
not differ according to the alcohol intake categories, in
either sex (ESM Fig. 2).
NEFA concentration In both men and women, there was a
significant increase in NEFA levels across alcohol intake
categories (Tables 1 and 2). This association persisted after
controlling for age, recruitment centre, waist, current smok-
ing and physical activity in men (ptrend00.0003) but not in
women (ptrend00.32).
Insulin clearance Alcohol consumption, expressed in cate-
gories, was significantly associated with an increased pe-
ripheral clearance of insulin during the clamp and enhanced
endogenous ‘pre-hepatic’ clearance of insulin in both basal
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conditions and during the OGTT in men and women
(Tables 3 and 4). The increased insulin clearance across
quartiles of alcohol intake in men was independent of
insulin sensitivity (M/I) in the multivariable model (Tables 3
and 4).
Glucagon concentration Fasting glucagon levels progres-
sively decreased across alcohol consumption categories in
both sexes, but with a significant trend for women only
(ptrend00.01, Fig. 3). In women, this association remained
significant after controlling for insulin sensitivity (M/I) in
Table 1 Baseline characteristics according to categories of alcohol consumption in men. The RISC study
Characteristic Alcohol consumption (g/week) pANOVA
Abstainers (n072) <57 (n0169) 57–130 (n0167) >130 (n0162)
Age (years) 41.2±7.9 43.5±8.4 43.5±8.8 43.6±8.6 0.20
BMI (kg/m2) 26.7±4.2 26.5±3.3 26.1±3.8 26.2±3.1 0.59
Waist circumference (cm) 93.8±11.8 93.4±9.7 93.0±11.0 93.6±9.2 0.93
Current smoking (%) 25.0 25.0 28.5 31.5 0.13
Physically inactive (%) 17.6 25.6 23.6 16.6 0.38
Systolic blood pressure (mmHg) 121.3±10 122.6±10 121.6±11 122.8±11 0.62
Diastolic blood pressure (mmHg) 75.7±7 76.9±7 75.9±8 76.9±7 0.43
Fasting glycaemia (mmol/l) 5.4±1.8 5.1±0.6 5.3±0.5 5.3±0.5 0.17
Fasting insulinaemia (pmol/l) 34.5 (38.0) 27.0 (22.9) 26.2 (21.2) 30.0 (25.0) 0.02
Fasting NEFA (mmol/l) 0.41 (0.26) 0.43 (0.25) 0.44 (0.20) 0.47 (0.28) 0.007
Total cholesterol (mmol/l) 4.64±0.9 4.86±0.9 4.90±0.8 4.98±0.9 0.05
LDL-cholesterol (mmol/l) 2.95±0.8 3.10±0.8 3.08±0.8 3.08±0.8 0.59
HDL-cholesterol (mmol/l) 1.14±0.3 1.24±0.3 1.24±0.3 1.26±0.3 0.05
Triacylglycerol (mmol/l) 1.04 (0.5) 1.08 (0.6) 1.08 (0.8) 1.16 (0.9) 0.13
Adiponectin (mg/l) 5.6 (2.4) 6.0 (3.2) 6.3 (3.7) 5.9 (3.1) 0.19
GGT (U/l) 26.0 (15.0) 25.0 (14.5) 25.0 (12.7) 28.0 (18.0) 0.007
Data are presented as mean±SD, median (interquartile range) or %
Table 2 Baseline characteristics according to categories of alcohol consumption in women. The RISC study
Characteristic Alcohol consumption (g/week) pANOVA
Abstainers (n0172) <28 (n0168) 28–64 (n0181) >64 (n0185)
Age (years) 43.4±8.4 44.1±8.1 44.5±8.1 44.8±8.1 0.41
BMI (kg/m2) 25.8±5.1 24.9±4.2 24.6±42 24.0±3.5 0.0007
Waist circumference (cm) 83.6±4.3 81.4±11.6 80.1±11.3 79.4±.7 0.006
Current smoking (%) 20.2 22.1 28.2 28.6 0.01
Physically inactive (%) 15.3 22.4 18.4 21.5 0.28
Systolic blood pressure (mmHg) 114.9±13 113.2±12 112.9±12 113.3±13 0.47
Diastolic blood pressure (mmHg) 73.9±8 72.5±8 71.9±8 72.7±8 0.10
Fasting glycaemia (mmol/l) 4.9±0.6 4.9±0.6 5.0±0.5 5.0±0.5 0.17
Fasting insulinaemia (pmol/l) 28.0 (25.7) 26.0 (18.0) 24.0 (21.1) 23.4 (16.0) 0.19
Fasting NEFA (mmol/l) 0.60 (0.28) 0.54 (0.25) 0.53 (0.25) 0.59 (0.26) 0.03
Total cholesterol (mmol/l) 4.71±0.9 4.89±0.9 4.70±0.8 4.81±0.8 0.13
LDL-cholesterol (mmol/l) 2.82±0.8 2.91±0.9 2.70±0.8 2.68±0.8 0.03
HDL-cholesterol (mmol/l) 1.45±0.3 1.54±0.3 1.59±0.4 1.70±0.4 <0.0001
Triacylglycerol (mmol/l) 0.86 (0.55) 0.85 (0.47) 0.85 (0.42) 0.80 (0.48) 0.56
Adiponectin (mg/l) 8.5 (5.1) 9.1 (5.0) 9.6 (5.1) 9.8 (4.8) 0.08
GGT (U/l) 16.0 (9.0) 17.0 (9.0) 17.0 (8.0) 19.0 (12.0) <0.0001
Data are presented as mean±SD, median (interquartile range) or %
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the multivariable model (ptrend00.02) and was also indepen-
dent of fasting glycaemia and fasting insulinaemia.
Impaired glucose tolerance and type 2 diabetes at 3 years
Alcohol consumption categories were not associated with
either fasting or 2 h glycaemia at year3 in either men or
women, analysed separately in multivariate models. There
was a reduced risk of IGT/diabetes at year3 for the women
with a baseline alcohol consumption above the median
value (>30 g/week) (OR 0.57, 95% CI 0.34, 0.94, p00.03)
after adjusting for age and waist circumference. In men,
baseline alcohol consumption above the median value
(>71 g/week) was not associated with a reduction in the
risk of IGT/diabetes at year3 (OR 1.02, 95% CI 0.57,
1.81, p00.95).
Discussion
The main finding of this study is that moderate alcohol
consumption is associated with an enhanced peripheral in-
sulin sensitivity, a reduced basal insulin secretion and a
lower fasting plasma glucagon concentration in healthy
women. This is in agreement with a large body of evidence
showing that moderate alcohol consumption is associated
with a decreased risk of type 2 diabetes in the general
population [1, 7, 16–18], including women at low risk [6,
19]. A meta-analysis reported a much more marked relation
in women than in men [7]. Similarly, a recent multicentre
prospective European study, with 12,403 incident cases of
type 2 diabetes and 16,154 controls, showed that moderate
alcohol consumption was associated with a reduced risk of
type 2 diabetes in women only [20].
Enhanced insulin sensitivity among moderate alcohol
drinkers has been reported previously, but most of these
studies used proxy estimates of insulin sensitivity, such as
the fasting insulin concentration or the HOMA of insulin
resistance (HOMA-IR) index, instead of the gold-standard
method of the euglycaemic–hyperinsulinaemic clamp, as
used in the present study [21–23].
Short-term intervention studies have shown an increase
in both insulin sensitivity and adiponectin concentration
within 3–8 weeks after alcohol intake [24–27]. Moderate
alcohol consumption for 4 weeks has been associated with a
12% increase in plasma adiponectin and a 57% increase in its
high-molecular-weight form, without concomitant changes in
subcutaneous and abdominal fat content or body weight [28];
adiponectin has been shown to account for 25–30% of the
inverse association between alcohol consumption and the risk
of type 2 diabetes in women [19]. Interestingly, in the present
study, the significant association between moderate alcohol
intake and improved insulin sensitivity in women persisted
after controlling for adiponectin concentration, suggesting that
other mechanisms may be involved. The pathophysiology
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underlying the effects of moderate alcohol intake on insulin
sensitivity is complex and not fully understood.
The final product of ethanol oxidation is acetate, which is
converted to acetyl-CoA in peripheral tissue [29]. Acetate
may modulate fat oxidation and decrease lipolysis. There-
fore, an increase in skeletal muscle oxidative capacity after
alcohol intake has been suggested even though evidence is
limited in humans [28].
HDL-cholesterol concentration increases with alcohol
consumption and is also related to insulin sensitivity and
adiponectin concentrations, and could be a key mediator in
the association between alcohol consumption and improved
glucose use [30]. In the present study, the relationship
between alcohol intake and HDL-cholesterol levels was
stronger in women than in men. Furthermore, the observa-
tion that the association between alcohol and insulin sensi-
tivity lost significance after further adjustment for HDL-
cholesterol concentration supports a greater role for HDL-
cholesterol, rather than for adiponectin, in the modulation of
insulin sensitivity by alcohol, in particular among women.
The effects of alcohol consumption on insulin secretion
have been investigated less extensively than its effects on
insulin sensitivity, in particular with a conjoint assessment
of insulin sensitivity. In the present study, we found that
light-to-moderate alcohol consumption was associated with
a decreased basal insulin secretion rate in non-diabetic
women, and this effect was independent of insulin sensitiv-
ity. This finding was confirmed when we assessed basal
insulin secretion at a fixed normal glucose level of
5 mmol/l glucose from the beta cell dose–response. These
results suggest that alcohol has a more pronounced effect on
basal insulin secretion rate than on glucose-load-induced
insulin response. Data on the effects of alcohol consumption
on insulin secretion are conflicting: some studies show the
absence of an association in men [31, 32] and others show a
decreased insulin secretion with men and women combined
[17]. The reasons for the absence of a significant association
between alcohol intake and insulin secretion in men in
contrast to women remain unclear, and may rely on sex
specificity. Adjustment for menopausal status did not
substantially modify the association between alcohol con-
sumption and either insulin sensitivity or secretion (data not
shown), suggesting that sex-specific effects may be related
to effects other than differences in hormone levels.
In agreement with our findings, an inverse association
between alcohol intake and insulin secretion has been noted
Table 3 Insulin clearance according to categories of alcohol consumption in men. The RISC study
Insulin clearance Alcohol consumption (g/week) ptrend ptrend
a
Abstainers (n070) <57 (n0167) 57–130 (n0165) >130 (n0162)
Peripheral clearance of insulin during the
clamp (1 min−1m−2)
0.58±0.15 0.59±0.15 0.63±0.2 0.63±0.26 0.003 0.02
Endogenous ‘pre-hepatic’ clearance of insulin
in basal conditions (1 min−1m−2)
2.11±0.71 2.45±0.94 2.36±0.78 2.44±0.78 0.04 0.05
Endogenous ‘pre-hepatic’ clearance of insulin
during OGTT (1 min−1m−2)
1.47±0.55 1.55±0.57 1.57±0.50 1.68±0.68 0.003 0.01
Data are presented as mean±SD
ptrend is adjusted for age, centre, physical activity, current smoking, waist circumference
a ptrend is additionally adjusted for insulin sensitivity, log M/I
Table 4 Insulin clearance according to categories of alcohol consumption in women. The RISC study
Insulin clearance Alcohol consumption (g/week) ptrend ptrend
a
Abstainers (n0171) <28 (n0166) 28–64 (n0181) >64 (n0184)
Peripheral clearance of insulin during the
clamp (1 min−1m−2)
0.62±0.41 0.63±0.19 0.63±0.13 0.64±0.22 0.04 0.49
Endogenous ‘pre-hepatic’ clearance of insulin
in basal conditions (1 min−1m−2)
2.28±0.76 2.29±0.72 2.43±0.81 2.53±0.80 0.22 0.53
Endogenous ‘pre-hepatic’ clearance of insulin
during OGTT (1 min−1m−2)
1.62±0.60 1.61±0.56 1.71±0.61 1.74±0.54 0.28 0.91
Data are presented as mean±SD
ptrend is adjusted for age, centre, physical activity, current smoking, waist circumference
a ptrend is additionally adjusted for insulin sensitivity, log M/I
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previously in non-diabetic women [33]. The decrease in
basal insulin secretion rate across alcohol consumption cate-
gories in women could be viewed as a direct consequence of
enhanced insulin sensitivity. Furthermore, exposure to physi-
ological hyperinsulinaemia stimulates insulin secretion in
non-diabetic individuals [14]. However, adjustment for insu-
lin sensitivity did not alter the inverse association, suggesting
alternative mechanisms. Furthermore, the effect of alcohol on
insulin secretion appears to be independent of the concomitant
increase in either HDL-cholesterol or adiponectin concentra-
tions. Therefore, the possibility of a specific effect of alcohol
on beta cell function needs to be further explored.
The present study showed that alcohol consumption was
significantly associated with an increased endogenous clear-
ance of insulin. This aspect has not previously been recog-
nised. Enhanced rates of insulin clearance across alcohol
intake categories may be related to concomitant increased
insulin sensitivity and reduced basal insulin secretion rate as
seen in the present study. Previous studies have underscored
the tight interactions between insulin sensitivity, insulin
secretion and insulin clearance [34–36]. In the presence of
insulin resistance, glucose homeostasis is maintained by an
increase in plasma insulin via increased secretion and a
decrease in insulin extraction. Animal studies have shown
that induction of insulin resistance induces an initial in-
crease in insulin secretion followed by a decrease in hepatic
insulin extraction [37].
The graded increase in NEFA concentration across alco-
hol consumption categories observed in the present study is
consistent with both the increased clearance of insulin and
reduced basal insulin secretion rate, observed in parallel
with increasing alcohol intake, as insulin inhibits lipolysis
and NEFA release in healthy individuals [38].
To our knowledge, the relationship between alcohol
and glucagon concentration has not been investigated
previously. Our finding of an inverse correlation between
alcohol consumption and fasting glucagon levels in
women suggests a putative new mechanism to explain
why moderate alcohol consumption is protective for the
development of type 2 diabetes. A direct effect of alco-
hol on the regulation of glucagon release warrants spe-
cific investigation. This inverse association between
glucagon and alcohol consumption appeared to be inde-
pendent of fasting glycaemia and of insulinaemia, sug-
gesting a specific, yet poorly characterised, direct effect
of alcohol on the regulation of glucagon release. This
novel finding of an inverse correlation between moderate
alcohol consumption and fasting glucagon concentrations
should also be tested in type 2 diabetes.
Limitations of the present study include its cross-
sectional design, which precludes drawing causal inferences
from the observed associations. Furthermore, our results
may have been influenced by differences in factors other
than alcohol intake. We cannot rule out confounding by
unmeasured variables. The difficulty of an accurate evalua-
tion of alcohol consumption with possible under-reporting
and misclassification should be acknowledged. However,
we intentionally excluded heavy drinkers in our study to
focus on abstainers and light-to-moderate drinkers.
The strengths of the present study are the large RISC
cohort of healthy participants, the use of the gold-standard
methodology for measurement of insulin sensitivity, use of
centralised laboratory assays with a quality control of data
and the assessment of both insulin secretion and insulin
clearance [8]. This provided the opportunity to systemati-
cally explore, in both men and women, the relationship
between alcohol consumption and insulin sensitivity, insulin
secretion, insulin clearance and glucagon concentrations.
In conclusion, our study shows that in healthy women,
light-to-moderate alcohol consumption is associated with
enhanced insulin sensitivity, decreased basal insulin
secretion rate, decreased fasting glucagon levels and an
increased insulin clearance. These findings provide potential
explanations for the reduced risk of type 2 diabetes associ-
ated with moderate alcohol consumption.
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Fig. 3 Fasting glucagon concentration according to categories of
alcohol consumption (in g/week) in men (a) and women (b). Data
are means±SEM. ptrend00.37 for men and ptrend00.01 for women,
adjusted for age, recruitment centre, physical activity, smoking and
waist circumference after a logarithmic transformation for glucagon
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